All Stories

  1. Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Recent Omicron COVID-19 Subtypes is Rare but Involves Severe Cardiovascular Features
  2. Post-daunorubicin treatment effects on cardiovascular function in the Ts65Dn mouse model of Down syndrome
  3. Abstract 4347921: Long-Term Survival in Pediatric Heart Transplantation: A PHTS-SRTR Linkage Study
  4. Practice Patterns in Pediatric Cardiothoracic Presurgical Conferences: A Multicenter Survey Study
  5. Relationship Between Central Venous Pressure, Cardiac Index, and Renal Function in Pediatric Heart Failure: a Pediatric Heart Transplant Society Study
  6. Acute cardiotoxicity in pediatric and adolescent patients with solid tumors treated with tyrosine kinase inhibitors
  7. COVID-19 and pediatric out-of-hospital cardiac arrest using U.S. registry database
  8. Prophylactic Use of Cardiac Medications and Survival in Duchenne Muscular Dystrophy
  9. Subsequent kidney transplant after pediatric heart transplant: Prevalence and risk factors
  10. Covid-19 and Pediatric Out of Hospital Cardiac Arrest Using U.S. Registry Database
  11. Uncertain benefit of statins in pediatric heart transplant recipients: A PHTS analysis
  12. Congestive Heart Failure in an Adolescent With a Ruptured Sinus of Valsalva Aneurysm
  13. Diffuse myocardial fibrosis occurs in young patients with sickle cell anemia despite early disease-modifying therapy
  14. Clinical approach to antibody‐mediated rejection from the pediatric heart transplant society
  15. The effects of cardio-selective β blockade on diastolic dysfunction in children with sickle cell disease
  16. Selumetinib for Refractory Pulmonary and Gastrointestinal Bleeding in Noonan Syndrome
  17. Permissive Cardiotoxicity
  18. Heart Transplantation in Children With Down Syndrome
  19. Myocardial Infarction at Mid-Term Follow-Up in a Teenager With Multisystem Inflammatory Syndrome in Children After COVID-19
  20. Pediatric Cardio-Oncology Medicine: A New Approach in Cardiovascular Care
  21. Assessment of Cardiac Abnormalities in Sickle Cell Disease Patients Using Cardiac Magnetic Resonance Imaging (CMR)
  22. Association of persistent tachycardia with early myocardial dysfunction in children undergoing allogeneic hematopoietic cell transplantation
  23. Clinical Insights Into Heritable Cardiomyopathies
  24. Left Ventricular Noncompaction and Vigorous Physical Activity
  25. Acquired and modifiable cardiovascular risk factors in patients treated for cancer
  26. Novel use of cangrelor in pediatrics: A pilot cohort study demonstrating use in ventricular assist devices
  27. ISHLT consensus statement on donor organ acceptability and management in pediatric heart transplantation
  28. Effects of donor cause of death, ischemia time, inotrope exposure, troponin values, cardiopulmonary resuscitation, electrocardiographic and echocardiographic data on recipient outcomes: A review of the literature
  29. Smallest child transplanted with the Syncardia Artificial Heart
  30. Use of a novel antiplatelet agent cangrelor in an infant supported with a ventricular assist device
  31. Anomalous Left Coronary Artery from the Pulmonary Artery (ALCAPA): a Systematic Review and Historical Perspective
  32. Use of echo to identify abnormalities in the Berlin Heart Device
  33. Successful Physical Rehabilitation After Placement of a SynCardia Total Artificial Heart
  34. Electrophysiological effects of anthracyclines in adult survivors of pediatric malignancy
  35. MURMURQUIZ: A TOOL FOR CARDIAC AUSCULTATION TRAINING AND EVALUATION
  36. The past, present, and future of paediatric cardiology training at the Johns Hopkins Hospital, in the tradition of Dr Helen Taussig